Novonix Valuation
| NVNXF Stock | USD 0.48 0.03 5.88% |
Novonix is overvalued. Novonix secures a last-minute Real Value of $0.4 per share. The latest price of the firm is $0.48. Our model forecasts the value of Novonix from analyzing the firm fundamentals such as Operating Margin of (7.36) %, shares outstanding of 485.95 M, and Return On Equity of -0.26 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Novonix's price fluctuation is out of control at this time. Calculation of the real value of Novonix is based on 3 months time horizon. Increasing Novonix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Novonix pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Novonix. Since Novonix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Novonix Pink Sheet. However, Novonix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.48 | Real 0.4 | Hype 0.48 | Naive 0.54 |
The real value of Novonix Pink Sheet, also known as its intrinsic value, is the underlying worth of Novonix Company, which is reflected in its stock price. It is based on Novonix's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Novonix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Novonix helps investors to forecast how Novonix pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Novonix more accurately as focusing exclusively on Novonix's fundamentals will not take into account other important factors: Novonix Total Value Analysis
Novonix is now anticipated to have takeover price of 534.72 M with market capitalization of 536.98 M, debt of 52.15 M, and cash on hands of 207.08 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Novonix fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
534.72 M | 536.98 M | 52.15 M | 207.08 M |
Novonix Investor Information
About 28.0% of the company outstanding shares are owned by corporate insiders. The book value of Novonix was now reported as 0.75. The company recorded a loss per share of 0.06. Novonix had not issued any dividends in recent years. Based on the key measurements obtained from Novonix's financial statements, Novonix is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Novonix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Novonix has an asset utilization ratio of 1.92 percent. This implies that the Company is making $0.0192 for each dollar of assets. An increasing asset utilization means that Novonix is more efficient with each dollar of assets it utilizes for everyday operations.Novonix Ownership Allocation
Novonix maintains a total of 485.95 Million outstanding shares. Novonix holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Novonix Profitability Analysis
The company reported the revenue of 8.42 M. Net Loss for the year was (71.44 M) with profit before overhead, payroll, taxes, and interest of 5.41 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Novonix's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Novonix and how it compares across the competition.
About Novonix Valuation
The pink sheet valuation mechanism determines Novonix's current worth on a weekly basis. Our valuation model uses a comparative analysis of Novonix. We calculate exposure to Novonix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Novonix's related companies.Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. Novonix Limited was incorporated in 2012 and is based in Brisbane, Australia. Novonix is traded on OTC Exchange in the United States.
8 Steps to conduct Novonix's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Novonix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Novonix's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Novonix's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Novonix's revenue streams: Identify Novonix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Novonix's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Novonix's growth potential: Evaluate Novonix's management, business model, and growth potential.
- Determine Novonix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Novonix's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Novonix Growth Indicators
Investing in growth stocks can be very risky. If the company such as Novonix does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 486 M | |
| Retained Earnings | -153.4 M |
Complementary Tools for Novonix Pink Sheet analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |